Abstract

CD32a has been proposed as a specific marker of latently HIV-infected CD4+ T cells. However, CD32a was recently found to be expressed on CD4+ T cells of healthy donors, leading to controversy on the relevance of this marker in HIV persistence. Here, we used mass cytometry to characterize the landscape and variation in the abundance of CD32a+ CD4+ T cells during HIV infection. To this end, we analyzed CD32a+ CD4+ T cells in primary HIV infection before and after effective combination antiretroviral therapy (cART) and in healthy donors. We found that CD32a+ CD4+ T cells include heterogeneous subsets that are differentially affected by HIV infection. Our analysis revealed that naive (N), central memory (CM), and effector/memory (Eff/Mem) CD32a+ CD4+ T-cell clusters that co-express LILRA2- and CD64-activating receptors were more abundant in primary HIV infection and cART stages. Conversely, LILRA2− CD32a+ CD4+ T-cell clusters of either the TN, TCM, or TEff/Mem phenotype were more abundant in healthy individuals. Finally, an activated CD32a+ CD4+ TEff/Mem cell cluster co-expressing LILRA2, CD57, and NKG2C was more abundant in all HIV stages, particularly during primary HIV infection. Overall, our data show that multiple abundance modifications of CD32a+ CD4+ T-cell subsets occur in the early phase of HIV infection, and some of which are conserved after effective cART. Our study brings a better comprehension of the relationship between CD32a expression and CD4+ T cells during HIV infection.

Highlights

  • Effective combination antiretroviral therapy leads to the control of HIV replication and disease progression in HIV-infected patients [1, 2]

  • We characterized the heterogeneity of CD32a+ CD4+ T-cell populations in primary HIV-infected patients, before and after effective combination antiretroviral therapy (cART), as well as in healthy donors, using a pan-leukocyte mass cytometry panel of 35 markers

  • Primary HIV infection referred to blood samples collected between 18 and 30 days after HIV infection (Fiebig stage III/IV) with a high-level plasma viral load including parameters described by Krastinova et al [27]

Read more

Summary

Introduction

Effective combination antiretroviral therapy (cART) leads to the control of HIV replication and disease progression in HIV-infected patients [1, 2]. Characterization of latently infected CD4+ T cells is required for the design of therapeutic strategies to target HIV reservoirs. In this respect, a recent study showed that the Fc receptor. CD32a ( known as FcγRIIa) could be a critical marker for a substantial portion of the latently HIV-infected CD4+ T cells that harbor replication-competent proviruses [7]. CD32a expression was reported on CD4+ T cells displaying HIV replication and on CD4+ T cells from healthy donors [8,9,10,11], leading to controversy over the relevance of this marker for the characterization of latent HIV reservoirs. Evaluating the heterogeneity of CD32a+ CD4+ T cells in early HIV infection, before and after effective cART, could be helpful to better characterize the relationship between CD32a expression and HIV infection

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call